SEARCH

SEARCH BY CITATION

References

  • Abdul Aziz, A.A., Finn, D.P., Mason, R. & Chapman, V. (2005) Comparison of responses of ventral posterolateral and posterior complex thalamic neurons in naive rats and rats with hindpaw inflammation: mu-opioid receptor mediated inhibitions. Neuropharmacology, 48, 607616.
  • Abeles, M. & Goldstein, M.H.J. (1977) Mutlispike train analysis. IEEE Trans. Biomed. Eng., 65, 762773.
  • Ashton, J.C., Friberg, D., Darlington, C.L. & Smith, P.F. (2006) Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci. Lett., 396, 113116.
  • Ashton, J.C., Rahman, R.M., Nair, S.M., Sutherland, B.A., Glass, M. & Appleton, I. (2007) Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain. Neurosci. Lett., 412, 114117.
  • Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S. & Reggiani, A. (2006) CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci., 23, 15301538.
  • Benito, C., Nunez, E., Tolon, R.M., Carrier, E.J., Rabano, A., Hillard, C.J. & Romero, J. (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci., 23, 1113611141.
  • Bordi, F. & Quartaroli, M. (2000) Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus. Pain, 84, 213224.
  • Cabral, G.A. & Marciano-Cabral, F. (2005) Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J. Leukocyte Biol., 78, 11921197.
  • Carlisle, S.J., Marciano-Cabral, F., Staab, A., Ludwick, C. & Cabral, G.A. (2002) Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int. Immunopharmacol., 2, 6982.
  • Carrier, E.J., Kearn, C.S., Barkmeier, A.J., Breese, N.M., Yang, W., Nithipatikom, K., Pfister, S.L., Campbell, W.B. & Hillard, C.J. (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol., 65, 9991007.
  • Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. & Yaksh, T.L. (1994) Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Meth., 53, 5563.
  • Chapman, V., Suzuki, R. & Dickenson, A.H. (1998) Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5–L6. J. Physiol. (Lond.), 507, 881894.
  • Chin, C.L., Tovcimak, A.E., Hradil, V.P., Seifert, T.R., Hollingsworth, P.R., Chandran, P., Zhu, C.Z., Gauvin, D., Pai, M., Wetter, J., Hsieh, G.C., Honore, P., Frost, J.M., Dart, M.J., Meyer, M.D., Yao, B.B., Cox, B.F. & Fox, G.B. (2008) Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. Br. J Pharmacol., 153, 367379.
  • Clayton, N., Marshall, F.H., Bountra, C. & O'Shaughnessy, C.T. (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain, 96, 253260.
  • Cooper, D.C. (2002) The significance of action potential bursting in the brain reward circuit. Neurochem. Int., 41, 333340.
  • Costa, B., Colleoni, M., Conti, S., Trovato, A.E., Bianchi, M., Sotgiu, M.L. & Giagnoni, G. (2004) Repeated treatment with the synthetic cannabinoid WIN 55,212–2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br. J. Pharmacol., 141, 48.
  • Csicsvari, J., Hirase, H., Czurko, A. & Buzsaki, G. (1998) Reliability and state dependence of pyramidal cell-interneuron synapses in the hippocampus: an ensemble approach in the behaving rat. Neuron, 21, 179189.
  • Elmes, S.J., Jhaveri, M.D., Smart, D., Kendall, D.A. & Chapman, V. (2004) Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur. J. Neurosci., 20, 23112320.
  • Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M. & Leon, A. (2003) Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia, 41, 161168.
  • Fanselow, E.E., Sameshima, K., Baccala, L.A. & Nicolelis, M.A. (2001) Thalamic bursting in rats during different awake behavioral states. Proc. Natl Acad. Sci. USA, 98, 1533015335.
  • Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L. & James, I. (2001) The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91100.
  • Gong, J.P., Onaivi, E.S., Ishiguro, H., Liu, Q.R., Tagliaferro, P.A., Brusco, A. & Uhl, G.R. (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res., 1071, 1023.
  • Guilbaud, G., Benoist, J.M., Jazat, F. & Gautron, M. (1990) Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy. J. Neurophysiol., 64, 15371554.
  • Hains, B.C., Saab, C.Y. & Waxman, S.G. (2006) Alterations in burst firing of thalamic VPL neurons and reversal by Na (v), 1.3 antisense after spinal cord injury. J. Neurophysiol., 95, 33433352.
  • Hanus, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R.G., Ross, R.A., Mechoulam, R. & Fride, E. (1999) HU-308: a specific agonist for CB (2), a peripheral cannabinoid receptor. Proc. Natl Acad. Sci. USA, 96, 1422814233.
  • Hasanein, P., Parviz, M., Keshavarz, M. & Javanmardi, K. (2007) CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Clin. Exp. Pharmacol. Physiol., 34, 439449.
  • Hong, L.J., Mubarak, W.A., Sunami, Y., Murakami, S., Fuyama, Y., Ohtsuka, A. & Murakami, T. (2000) Enhanced visualization of weak colloidal iron signals with Bodian's protein silver for demonstration of perineuronal nets of proteoglycans in the central nervous system. Arch. Histol. Cytol., 63, 459465.
  • Howlett, A.C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol., 35, 607634.
  • Ibrahim, M.M., Deng, H., Zvonok, A., Cockayne, D.A., Kwan, J., Mata, H.P., Vanderah, T.W., Lai, J., Porreca, F., Makriyannis, A. & Malan, T.P. Jr (2003) Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS. Proc. Natl Acad. Sci. USA, 100, 1052910533.
  • Jafari, M.R., Golmohammadi, S., Ghiasvand, F., Zarrindast, M.R. & Djahanguiri, B. (2007) Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133) -induced antinociception in mice. Behav. Pharmacol., 18, 691697.
  • Jhaveri, M.D., Richardson, D., Kendall, D.A., Barrett, D.A. & Chapman, V. (2006) Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci., 26, 1331813327.
  • Kim, S.H. & Chung, J.M. (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain, 50, 355363.
  • Klegeris, A., Bissonnette, C.J. & McGeer, P.L. (2003) Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br. J. Pharmacol., 139, 775786.
  • Krahe, R. & Gabbiani, F. (2004) Burst firing in sensory systems. Nat. Rev. Neurosci., 5, 1323.
  • Krupa, D.J., Ghazanfar, A.A. & Nicolelis, M.A. (1999) Immediate thalamic sensory plasticity depends on corticothalamic feedback. Proc. Natl Acad. Sci. USA, 96, 82008205.
  • Lichtman, A.H., Cook, S.A. & Martin, B.R. (1996) Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J. Pharmacol. Exp. Ther., 276, 585593.
  • Liu, C. & Walker, J.M. (2006) Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain. J. Neurophysiol., 96, 29842994.
  • Malan, T.P. Jr, Ibrahim, M.M., Lai, J., Vanderah, T.W., Makriyannis, A. & Porreca, F. (2003) CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr. Opin. Pharmacol., 3, 6267.
  • Martin, W.J., Coffin, P.O., Attias, E., Balinsky, M., Tsou, K. & Walker, J.M. (1999) Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res., 822, 237242.
  • Nackley, A.G., Makriyannis, A. & Hohmann, A.G. (2003) Selective activation of cannabinoid CB (2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience, 119, 747757.
  • Nunez, E., Benito, C., Pazos, M.R., Barbachano, A., Fajardo, O., Gonzalez, S., Tolon, R.M. & Romero, J. (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse, 53, 208213.
  • Palazzo, E., De Novellis, V., Petrosino, S., Marabese, I., Vita, D., Giordano, C., Di Marzo, V., Mangoni, G.S., Rossi, F. & Maione et al. (2006) Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur. J. Neurosci., 24, 20112020.
  • Paxinos, G. & Watson, C. (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, California, USA
  • Pertwee, R.G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther, 74, 129180.
  • Petrosino, S., Palazzo, E., De Novellis, V., Bisogno, T., Rossi, F., Maione, S. & Di Marzo, V. (2007) Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology, 52, 415422.
  • Richardson, D., Ortori, C.A., Chapman, V., Kendall, D.A. & Barrett, D.A. (2007) Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem., 360, 216226.
  • Robinson, B.W. & Mishkin, M. (1968) Penile erection evoked from forebrain structures in Macaca mulatta. Arch. Neurol., 19, 184198.
  • Sagar, D.R., Kelly, S., Millns, P.J., O'Shaughnessey, C.T., Kendall, D.A. & Chapman, V. (2005) Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur. J. Neurosci., 22, 371379.
  • Sanson, M., Bueno, L. & Fioramonti, J. (2006) Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats. Neurogastroenterol. Motil., 18, 949956.
  • Scott, D.A., Wright, C.E. & Angus, J.A. (2004) Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Pain, 109, 124131.
  • Siegling, A., Hofmann, H.A., Denzer, D., Mauler, F. & De Vry, J. (2001) Cannabinoid CB (1) receptor upregulation in a rat model of chronic neuropathic pain. Eur. J. Pharmacol., 415, R5R7.
  • Valenzano, K.J., Tafesse, L., Lee, G., Harrison, J.E., Boulet, J.M., Gottshall, S.L., Mark, L., Pearson, M.S., Miller, W., Shan, S., Rabadi, L., Rotshteyn, Y., Chaffer, S.M., Turchin, P.I., Elsemore, D.A., Toth, M., Koetzner, L. & Whiteside, G.T. (2005) Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology, 48, 658672.
  • Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J.S., Marnett, L.J., Di Marzo, V., Pittman, Q.J., Patel, K.D. & Sharkey, K.A. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 310, 329332.
  • Walczak, J.S., Pichette, V., Leblond, F., Desbiens, K. & Beaulieu, P. (2005) Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience, 132, 10931102.
  • Walczak, J.S., Pichette, V., Leblond, F., Desbiens, K. & Beaulieu, P. (2006) Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes. J. Neurosci. Res., 83, 13101322.
  • Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K. & Stella, N. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci., 23, 13981405.
  • Whiteside, G.T., Gottshall, S.L., Boulet, J.M., Chaffer, S.M., Harrison, J.E., Pearson, M.S., Turchin, P.I., Mark, L., Garrison, A.E. & Valenzano, K.J. (2005) A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833. Eur. J. Pharmacol., 528, 6572.
  • Wotherspoon, G., Fox, A., McIntyre, P., Colley, S., Bevan, S. & Winter, J. (2005) Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience, 135, 235245.
  • Zhang, J., Hoffert, C., Vu, H.K., Groblewski, T., Ahmad, S. & O'Donnell, D. (2003) Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci., 17, 27502754.